BPC-157 should be evaluated by a provider who can review your medical history, symptoms, medications, and goals before recommending treatment
Community discussion of this route is comparatively sparse, and no human data exists for any route
Jan 1 2021;26(3):401-430
BPC-157, for instance, has not yet been the subject of intensive human clinical trials, despite its popularity among tech-industry grindsetters, longevity bros, and pilates girlies alike
Neither BPC-157 nor TB-500 is an approved medicine
Medication Documentation: While the medication is billed separately, providers must document the name, dosage, and route of administration for the injected substance